1. Clinical & Scientific Overview
Benfotiamine (Vitamin B1) (TIP-MED-000388, Reference Code [10.12]-C118) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation & Transketolase (Schedule H / OTC | NLEM 2022).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Co-indexed constituent under primary monograph [10.12] (Thiamine Hydrochloride / Benfotiamine (Vitamin B1)). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.12], p. 132): Thiamine HCl: Benerva (Abbott — 100 mg Tab), Thiamin (IV 100 mg/mL). Benfotiamine (Lipid-Soluble Prodrug): Benalgis (Franco-Indian — 100 mg), Benforce — Strengths & Dosage Forms: Thiamine HCl Tablets: 100 mg; IV/IM Injection: 100 mg/mL (2 mL = 200 mg). Benfotiamine Tablets: 100 mg, 150 mg
Thiamine HCl Tablets: 100 mg; IV/IM Injection: 100 mg/mL (2 mL = 200 mg). Benfotiamine Tablets: 100 mg, 150 mg
3. Mechanism of Action & Pharmacodynamics
Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation & Transketolase (Schedule H / OTC | NLEM 2022) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation & Transketolase (Schedule H / OTC | NLEM 2022) for Prevention and emergency treatment of Wernicke's Encephalopathy / Korsakoff's Psychosis (in chronic alcohol use disorder, hyperemesis gravidarum, or starvation/refeeding), dry/wet Beriberi, and diabetic/alcoholic peripheral neuropathy.
4. Therapeutic Indications & Evidence-Supported Uses
- Prevention and emergency treatment of Wernicke's Encephalopathy / Korsakoff's Psychosis (in chronic alcohol use disorder, hyperemesis gravidarum, or starvation/refeeding), dry/wet Beriberi, and diabetic/alcoholic peripheral neuropathy
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Wernicke Encephalopathy Treatment: 500 mg IV infusion in 100 mL NS over 30 min TDS for 3–5 days, followed by 250 mg IV/IM OD for 3–5 days, then 100 mg PO TDS. Alcohol Withdrawal Prophylaxis: 100–200 mg IV/IM OD x 3–5d, then 100 mg PO BD–TDS. Neuropathy: Benfotiamine 100–150 mg PO OD–BD
Administration & Meal Timing: CRITICAL EMERGENCY RULE ('THIAMINE BEFORE GLUCOSE!'): In any malnourished, alcoholic, or vomiting (hyperemesis gravidarum) patient, ALWAYS administer IV Thiamine (100–500 mg) BEFORE or simultaneously with IV Dextrose/Glucose! Giving IV Dextrose first precipitates irreversible acute Wernicke's haemorrhage! | Oral: Morning & Evening with meals (BD) or OD
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Follows class pharmacokinetic profile detailed in parent monograph [10.12].
Renal & Hepatic: Water-soluble vitamin — safe in all stages of CKD and essential in alcoholic cirrhosis!
Renal & Hepatic: Water-soluble vitamin — safe in all stages of CKD and essential in alcoholic cirrhosis!
Renal & Hepatic: Water-soluble vitamin — safe in all stages of CKD and essential in alcoholic cirrhosis!
7. Contraindications, Precautions & High-Risk Warnings
- Parenteral IV Thiamine carries a small risk (<0.1%) of anaphylactoid reaction if pushed rapidly undiluted — always dilute IV Thiamine in 50–100 mL Normal Saline and infuse over 30 minutes!
Key Clinical Precautions: Renal & Hepatic: Water-soluble vitamin — safe in all stages of CKD and essential in alcoholic cirrhosis!
8. Adverse Effects Profile
- Oral Thiamine and Benfotiamine are virtually free of adverse effects; mild nausea or warmth on IV infusion
- Rare anaphylaxis with rapid undiluted IV bolus
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Chronic Loop Diuretics (Furosemide/Torsemide in Heart Failure) increase urinary Thiamine loss; 5-Fluorouracil inhibits thiamine phosphorylation
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.12].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Essential nerve and brain-protecting vitamin in anyone with heavy alcohol use, severe pregnancy vomiting, or diabetic nerve tingling; hospital staff must always give IV Thiamine before IV Glucose drips in malnourished or alcoholic patients
- Meal & Clock Timing Instruction: CRITICAL EMERGENCY RULE ('THIAMINE BEFORE GLUCOSE!'): In any malnourished, alcoholic, or vomiting (hyperemesis gravidarum) patient, ALWAYS administer IV Thiamine (100–500 mg) BEFORE or simultaneously with IV Dextrose/Glucose! Giving IV Dextrose first precipitates irreversible acute Wernicke's haemorrhage! (Oral: Morning & Evening with meals (BD) or OD)
- Missed Dose Protocol: Take with next meal if missed
- Geriatric Dispensing Pearl: Safe and frequently deficient in malnourished older adults and chronic heart failure patients on Furosemide
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Thiamine HCl Tablets: 100 mg; IV/IM Injection: 100 mg/mL (2 mL = 200 mg). Benfotiamine Tablets: 100 mg, 150 mg
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.5] Calcium Carbonate (Typically Combined with Vitamin D3) — Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Y
- [10.6] Calcium Citrate / Calcium Citrate Malate (CCM) — Organic Acid-Independent Soluble Calcium Salt (~21–24% Elemental
- [10.9] Zinc (Zinc Sulphate Monohydrate / Zinc Acetate / Zinc Gluconate) — Essential Trace Element Cofactor (>300 Metalloenzymes: DNA/RNA Po
- [10.10] Oral Magnesium Salts (Magnesium Oxide, Citrate & Bisglycinate — Nutritional) — Essential Intracellular Divalent Cation (Cofactor for >300 ATP-De